RELY vs. CLOV
RELY (Remitly Global, Inc.) and CLOV (Clover Health Investments, Corp.) are both stocks. RELY operates in Software - Infrastructure (Technology), while CLOV operates in Healthcare Plans (Healthcare). Over the past 3 years, RELY returned -1.32%/yr vs 57.67%/yr for CLOV. At a 0.36 correlation, their price movements are largely independent.
Performance
RELY vs. CLOV - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, RELY achieves a 33.70% return, which is significantly lower than CLOV's 66.81% return.
RELY
- 1D
- -1.70%
- 1M
- -23.22%
- YTD
- 33.70%
- 6M
- 36.57%
- 1Y
- -14.35%
- 3Y*
- -1.32%
- 5Y*
- —
- 10Y*
- —
CLOV
- 1D
- 2.35%
- 1M
- 25.64%
- YTD
- 66.81%
- 6M
- 53.13%
- 1Y
- 28.31%
- 3Y*
- 57.67%
- 5Y*
- -25.36%
- 10Y*
- —
RELY vs. CLOV - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
RELY Remitly Global, Inc. | 33.70% | -38.86% | 16.22% | 69.61% | -44.47% | -57.44% |
CLOV Clover Health Investments, Corp. | 66.81% | -25.40% | 230.85% | 2.43% | -75.01% | -52.91% |
Correlation
The correlation between RELY and CLOV is 0.29, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.29 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.22 |
Correlation (All Time) Calculated using the full available price history since Sep 24, 2021 | 0.36 |
The correlation between RELY and CLOV shifts across timeframes, from 0.22 (3 years) to 0.36 (all time), reflecting how their relationship changes across market environments.
Fundamentals
RELY:
$4.00B
CLOV:
$2.05B
RELY:
$0.49
CLOV:
-$0.11
RELY:
2.32
CLOV:
0.91
RELY:
4.41
CLOV:
6.03
RELY:
$1.73B
CLOV:
$2.21B
RELY:
$753.03M
CLOV:
$939.14M
RELY:
$142.85M
CLOV:
-$55.21M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
RELY vs. CLOV — Risk / Return Rank
RELY
CLOV
RELY vs. CLOV - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Remitly Global, Inc. (RELY) and Clover Health Investments, Corp. (CLOV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| RELY | CLOV | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.67 | ||
| Sortino ratioReturn per unit of downside risk | -1.08 | ||
| Omega ratioGain probability vs. loss probability | 1.00 | 1.14 | -0.14 |
| Calmar ratioReturn relative to maximum drawdown | -0.35 | 0.51 | -0.86 |
| Martin ratioReturn relative to average drawdown | -0.63 | 0.93 | -1.56 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| RELY | CLOV | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -0.26 | 0.41 | -0.67 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | — | -0.33 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.32 | -0.17 | -0.14 |
Drawdowns
RELY vs. CLOV - Drawdown Comparison
The maximum RELY drawdown since its inception was -85.80%, smaller than the maximum CLOV drawdown of -97.19%. Use the drawdown chart below to compare losses from any high point for RELY and CLOV.
Loading charts...
Drawdown Indicators
| RELY | CLOV | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -85.80% | -97.19% | +11.39% |
Max Drawdown (1Y)Largest decline over 1 year | -40.89% | -55.50% | +14.61% |
Max Drawdown (3Y)Largest decline over 3 years | -57.92% | -64.73% | +6.81% |
Max Drawdown (5Y)Largest decline over 5 years | — | -95.86% | — |
Current DrawdownCurrent decline from peak | -61.92% | -82.30% | +20.38% |
Average DrawdownAverage peak-to-trough decline | -64.50% | -76.63% | +12.13% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 25.50% | 30.48% | -4.98% |
Volatility
RELY vs. CLOV - Volatility Comparison
The current volatility for Remitly Global, Inc. (RELY) is 13.97%, while Clover Health Investments, Corp. (CLOV) has a volatility of 23.92%. This indicates that RELY experiences smaller price fluctuations and is considered to be less risky than CLOV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| RELY | CLOV | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 13.97% | 23.92% | -9.95% |
Volatility (6M)Calculated over the trailing 6-month period | 38.48% | 40.34% | -1.86% |
Volatility (1Y)Calculated over the trailing 1-year period | 55.84% | 69.47% | -13.63% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 59.08% | 78.08% | -19.00% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 59.08% | 85.65% | -26.57% |
Dividends
RELY vs. CLOV - Dividend Comparison
Neither RELY nor CLOV has paid dividends to shareholders.
Financials
RELY vs. CLOV - Financials Comparison
This section allows you to compare key financial metrics between Remitly Global, Inc. and Clover Health Investments, Corp.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
RELY vs. CLOV - Profitability Comparison
RELY - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Remitly Global, Inc. reported a gross profit of 0.00 and revenue of 452.80M. Therefore, the gross margin over that period was 0.0%.
CLOV - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Clover Health Investments, Corp. reported a gross profit of 692.13M and revenue of 749.19M. Therefore, the gross margin over that period was 92.4%.
RELY - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Remitly Global, Inc. reported an operating income of 53.74M and revenue of 452.80M, resulting in an operating margin of 11.9%.
CLOV - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Clover Health Investments, Corp. reported an operating income of 27.33M and revenue of 749.19M, resulting in an operating margin of 3.7%.
RELY - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Remitly Global, Inc. reported a net income of 49.05M and revenue of 452.80M, resulting in a net margin of 10.8%.
CLOV - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Clover Health Investments, Corp. reported a net income of 27.33M and revenue of 749.19M, resulting in a net margin of 3.7%.
Frequently Asked Questions
RELY and CLOV have a correlation of 0.29, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
CLOV has higher volatility (23.92%) compared to RELY (13.97%). In terms of maximum drawdown, RELY dropped -85.80% vs CLOV's -97.19%.
CLOV currently has the higher Sharpe Ratio (0.41 vs -0.26), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for RELY and CLOV
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer